Early Reassessment of Intravenous Antiinfective Therapy Due to "Antiinfective Reminders" (AIR Study)

Infection as Complication of Medical Care Clinical Trial

— AIR  

Official title:

Early Reassessment of Intravenous Antiinfective Therapy Due to "Antiinfective Reminders" (AIR Study)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01499927
• Other study ID #: FZMI-KEK-ZH-Nr. 2010-0457
• Status: Completed
• Phase: N/A
• First received: November 15, 2011
• Last updated: December 18, 2013
• Start date: January 2012
• Est. completion date: December 2012

Study information

• Verified date: December 2013
• Source: University of Zurich
• Contact: n/a
• Is FDA regulated: No
• Health authority: Switzerland: Ethikkommission
• Study type: Interventional

Clinical Trial Summary

Switching from intravenous application of antiinfective agents to oral therapy is often performed late including high costs and risk of complications. This study will investigate the impact of displayed reminders in the electronic patient chart after 60h of intravenous therapy with an antiinfective agent.

Description:

Switching from intravenous application of antiinfective agents to oral therapy is often performed late including high costs, risk of complications as well as higher workload on nursing. This study will investigate the impact of displayed reminders in the electronic patient chart after 60h of intravenous therapy with an antiinfective agent.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 74766
• Est. completion date: December 2012
• Est. primary completion date: December 2012
• Accepts healthy volunteers: No
• Gender: Both
• Age group: N/A and older

Eligibility

Inclusion criteria:

• all in-patients in treatment with an intravenous antiinfective for >60h,

• hospitalized in a ward with computerized physician order entry (cpoe)

Exclusion criteria:

• outpatients,

• ward without cpoe,

• no intravenous antiinfective treatment

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Health Services Research

Related Conditions & MeSH terms

• Infection as Complication of Medical Care

Intervention

Other:
• electronic reminders
Behavioral: Early switching from intravenous to oral antiinfective agents due to electronic reminders

Locations

Country	Name	City	State
Switzerland	University Hospital Zurich, Center for Clinical Research	Zurich	ZH

Sponsors (1)

Lead Sponsor	Collaborator
University of Zurich

Country where clinical trial is conducted

Switzerland, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	duration of intravenous antiinfective therapy until switching		1 year	No
Secondary	costs (per year, per day and patient)		1 year	No
Secondary	defined daily doses (per 100 days)		1 year	No
Secondary	duration of hospitalization		1 year	No
Secondary	ratio of narrow to broad-spectrum antibiotics		1 year	No
Secondary	requests for consultations		1 year	No